저자: CathieWood · 외국인
요약 보기
결론: 캐시 우드는 ARK 포트폴리오가 향후 5년간 연 20% 안팎 복리 수익을 낼 것으로 보며, 진행자는 ARK ETF를 조정 시 분할 매수하라고 권한다. [ARK 포트폴리오 전망] 캐시 우드는 5년 시계로 연 20% 초반 복리 수익을 기대하며 포트폴리오가 두 배 이상 될 것이라 말한다. 전통적 주식 수익률은 연 7~8% 수준으로 제시. [조정 전망] 과거 경험상 급등 후 조정이 온다고 보며 일정 부분 차익 실현과 여력(현금) 유지를 권고. 다만 장기 성장 궤적은 막을 수 없다고 봄. [유망 분야] 가장 큰 상방 서프라이즈는 게놈 분야(DNA 시퀀싱, AI, 유전자 치료, CRISPR 결합)에서 나올 것이라 주장. 테슬라는 여전히 유효하다고 언급. 베타 지중해빈혈, 겸상적혈구빈혈, 당뇨 등을 적용 대상으로 제시. [성과 귀속] ARK 성과 600포인트 중 애플·마이크로소프트·아마존·페이스북 기여는 약 20포인트에 불과하다고 지적. 이들은 초기 포트폴리오 편입 종목이었으나 조원 달러 규모 진입 후 다음 FANG을 찾는다고 설명. [진행자 전략] 진행자는 ARK를 개인적으로 80달러 부근부터 매수해 왔고 현재 130달러 수준이라 봄. 1만 달러 기준 현재 3천 달러 매수, 100달러 부근 조정 시 추가 3천 달러, 나머지 자금 투입 제안. 130달러 위 추가 매수는 시장 리스크 해소 시로 한정. [리스크] 진행자는 단기 조정 또는 급락 가능성을 인정하며 분할 접근을 강조. 캐시 우드 본인도 조정 가능성 언급. [출연자 전망 요약] 캐시 우드: 장기 강세, 단기 조정 가능성 인정. 진행자: ARK 단기 조정 시 분할 매수 전략 지지, ARK가 S&P500을 장기 상회 예상.
다듬은 글
hey guys what's up spending here so i have a super exciting video for you today kathy wood talks about what kind of return you can expect to see on your money by investing into arc and then she also talks about the next fang stocks and so i'm gonna break down these next fang stocks and i'll explain to you guys how i'm going to play this so make sure you watch this video to the end i think you're gonna find it very informative to enjoy being a rock star even if it's just for a moment right you're you're enjoying potentially life-changing success um most certainly but i have been around the block a few times the track a few times and whenever things have gone this well for me uh usually there's a correction around the bend and i want to gird for it and protect it and also prepare our investors for the possibility and say just keep some powder dry because what we're looking at here are long-term uh again exponential growth trajectories that uh they're not going to be stopped uh you can't stop progress uh and today when the government tries to stock progress uh well it usually fails and so even if we go through a correction and i i ex i expect one uh we must all almost always expect corrections uh i i just have to keep my eye on the prize but i i do want to warn uh investors that you know in the investment world it's not just straight up and to the right you know we will have those corrections so again we just keep our eye on the prize we have a five-year time horizon we are fully invested at all times which is what we are supposed to be uh but that doesn't mean that investors shouldn't you know sometimes take a bit of money off the table and keep some powder dry and we have projections which uh which we develop from the top down trying to understand how technologies are going to scale and from the bottom up how companies are going to embrace these new technologies and ride their coattails and uh just looking at the portfolios today this is after the triple digit gain as you uh have said uh for the next five years we believe that our returns will compound at an annual rate of something in the low 20 percent range and this is in a market where uh traditional equity returns have been in the seven to eight percent range over time so the portfolio may not be able to replicate the 500 plus percent gain it's had in the past five years but it should be based on what you just told me well over 100 percent it should double plus in this in the next five years yes we we expect more than a doubling in our portfolios over the next five years which of your current holdings kathy do you think will supply the biggest lift in the next five years tesla's still in the running but i would have to say the biggest upside surprises are going to come from the genomic space and that's because the convergence of dna sequencing artificial intelligence and gene therapies importantly crispr gene editing are going to cure disease that convergence is going to cure disease now we have real science and technology surfacing the mutations in our genomic profile and and as they surface those mutations what do we see we see the earliest manifestations of disease and now with the combination of artificial intelligence and gene editing we're able to both anticipate diseases and cure them potentially beta thalassemia we're seeing it sickle cell disease we even think it will work in uh diabetes which is where most the if you look at the largest category of spending uh year-to-year in health care it's diabetes kathy another surprise for me in your portfolio attribution is that almost none of your performance just 20 points out of 600 points is from apple microsoft amazon and facebook the four biggest contributors to the s p 500 over the same period what about them does it make the grade for kathy wood and for arc well we're not saying they'll be bad stocks at all in fact they've been very good stocks and they were a part of our portfolios in the early days uh but as they were scaling into the trillion dollar category we believed that our uh that that our research would be focused better on the next set of fangs and i don't mean fangs meaning in the internet age uh we actually think the next fangs are in the genomic age okay guys so first thing i want to talk about is investing into arc and then we're going to get into these next fang stocks so i'm personally invested in the ark i've been recommending this etf since it was 80 a share now we're trading at 130 a share so if you're not yet invested into them what i would do personally because it's ran from about 50 to 130 over the last year so it has ran a lot but i do still think now is a good buying opportunity but it's different it's not the same as investing as it was a year ago so say you have ten thousand dollars what i would do personally this is just what i would do so what i would do right now is i would put three thousand out of that ten thousand in right now the next trading day i wouldn't add any more to that though if it continues to run up i'd be looking for a correction and if it does correct bam i would smack another three thousand dollars into it if it traded anywhere around a hundred dollars if it goes below a hundred you you throw in the rest of that three to four thousand dollars you put the rest of that 10 grand into this etf um the only way i would add more into this etf above 130 where it is right now is if all of the market risks are gone right now there's a lot of upcoming catalysts which is basically scaring investors that the stock market could have a big correction or a crash in the near term and even kathy what in the interview does talk about a possible correction happening so that's why i wouldn't go all into it right now but you want skin in the game so i would do that strategy and the only way i would add above 130 is if all those catalysts disappear and we're not anticipating a possible correction so yeah that's how i play that and arc has a really good track record so over the past five years they've averaged a 30 return year over year guys this is comparable to peter lynch who's the greatest fund manager of all time i've read tons of his books he's an amazing investor uh one up on wall street is probably my favorite book by him if you have a chance definitely read it you will learn lots um so i think kathy wood is very comparable to him she's expecting a 20 return from here on out that is still close to what peter lynch managed over a 10-year time peter lynch managed 29.2 percent over about 10 years uh kathy wood is probably very comparable to that so this is an amazing opportunity just to throw your money into an etf and have one of the best fund managers of all time grow your money and then another reason why this is such a great idea too is because of these next fang stocks so kathy wood believes this is going to be in the genomic space now me personally and i think about 99.9 of all other investors we don't fully understand this genomic space and the companies within it i don't understand the technology i don't know what companies are better than others i wouldn't personally know when to buy or when to sell so i would feel a lot more comfortable putting my money into an arc fund they have all of the best analysts in the world they have way more access to information than we do they understand the research they know when to buy and they know when to sell out of these so i think the safest way to play the possible next fang stocks is by putting your money into arc that's what i'm doing personally i've been investing into ark since 80 a share i haven't put any more money into it since then because i'm kind of waiting for a correction now if we do see a 20 correction in the market i'm doubling down at arc i'm putting a lot more money into this etf personally i'd way rather be into this etf than something like the s p 500 this historically has returned to way more and i think moving forward into the future it's going to be no different arc is going to way out perform the s p 500 uh so yeah guys that's kind of my thoughts on how to play arc and the next fang stocks um i have a lot of faith in kathy wood and her team and i know a lot of other retail investors do as well uh anyways guys if you like this video make sure to drop a big thumbs up and feel free to subscribe if you want to see more content like this i do cover stocks every day of the week and thanks for watching till the end i'll see you guys in the next video
Comments 0